Microcystin–leucine–arginine causes blood–testis barrier disruption and degradation of occludin mediated by matrix metalloproteinase-8
- 408 Downloads
Microcystin–leucine–arginine (MC-LR) can cause male reproductive disorders. However, the underlying mechanisms are not yet fully understood. In this study, we aimed to investigate the effects of MC-LR on the integrity of blood–testis barrier (BTB) and the related molecular mechanisms. Both transepithelial electrical resistance measurement in vitro and electron microscope observation ex vivo revealed that MC-LR caused disruption of the tight junction between Sertoli cells, which was paralleled by the degradation of occludin. We observed increased expression of matrix metalloproteinase-8 (MMP-8) upon exposure to MC-LR, and confirmed that abrogation of MMP-8 activity by specific inhibitors as well as transfection with MMP-8 shRNA could abolish the degradation of occludin. Our data demonstrated that MC-LR up-regulated nuclear levels of c-Fos and c-Jun through activating ERK and JNK, and increased NF-κB levels by activating the phosphatidylinositol 3-kinase (PI3K)/AKT cascades. Enhanced binding of c-Fos and NF-κB to the promoter of MMP-8 promoted the transcription of MMP-8 gene. Furthermore, miR-184-3p was significantly downregulated in SC following exposure to MC-LR through targeting MMP-8 expression. Together, these results confirmed that MC-LR-induced MMP-8 expression was regulated at both transcriptional and post-transcriptional levels, which was involved in MC-LR-induced degradation of occludin and BTB destruction. This work may provide new perspectives in developing new diagnosis and treatment strategies for MC-induced male infertility.
KeywordsMicrocystin–leucine–arginine MMP-8 Transcriptional and post-transcriptional levels Occludin degradation
Fetal bovine serum
Phosphatidylinositol 3-kinase (PI3K)
Transepithelial electrical resistance
This work was supported by National Natural Science Foundation of China (31370524, 21377052, and 31670519) and Fundamental Research Funds for the Central Universities (021414380332).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interests.
- 6.Li Y, Chen JA, Zhao Q, Pu C, Qiu Z, Zhang R, Shu W (2011) A cross-sectional investigation of chronic exposure to microcystin in relationship to childhood liver damage in the Three Gorges Reservoir Region, China. Environ Health Perspect 119(10):1483–1488. doi: 10.1289/ehp.1002412 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Ding J, Wang J, Xiang Z, Diao W, Su M, Shi W, Wan T, Han X (2017) The organic anion transporting polypeptide 1a5 is a pivotal transporter for the uptake of microcystin-LR by gonadotropin-releasing hormone neurons. Aquat Toxicol 182:1–10. doi: 10.1016/j.aquatox.2016.11.005 CrossRefPubMedGoogle Scholar
- 12.Lin H, Liu W, Zeng H, Pu C, Zhang R, Qiu Z, Chen JA, Wang L, Tan Y, Zheng C, Yang X, Tian Y, Huang Y, Luo J, Luo Y, Feng X, Xiao G, Feng L, Li H, Wang F, Yuan C, Wang J, Zhou Z, Wei T, Zuo Y, Wu L, He L, Guo Y, Shu W (2016) Determination of environmental exposure to microcystin and aflatoxin as a risk for renal function based on 5493 rural people in southwest China. Environ Sci Technol 50(10):5346–5356. doi: 10.1021/acs.est.6b01062 CrossRefPubMedGoogle Scholar
- 22.Abdul Muneer PM, Alikunju S, Szlachetka AM, Haorah J (2012) The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion. Arterioscler Thromb Vasc Biol 32(5):1167–1177. doi: 10.1161/ATVBAHA.112.247668 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Ren C, Li N, Wang B, Yang Y, Gao J, Li S, Ding Y, Jin K, Ji X (2015) Limb ischemic perconditioning attenuates blood-brain barrier disruption by inhibiting activity of MMP-9 and occludin degradation after focal cerebral ischemia. Aging Dis 6(6):406–417. doi: 10.14336/AD.2015.0812 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Ichikawa Y, Ishikawa T, Momiyama N, Kamiyama M, Sakurada H, Matsuyama R, Hasegawa S, Chishima T, Hamaguchi Y, Fujii S, Saito S, Kubota K, Hasegawa S, Ike H, Oki S, Shimada H (2006) Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol Rep 15(2):311–315PubMedGoogle Scholar
- 27.Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M (2010) Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog 6(4):e1000874. doi: 10.1371/journal.ppat.1000874 CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Moon SK, Cha BY, Kim CH (2004) ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 198(3):417–427. doi: 10.1002/jcp.10435 CrossRefPubMedGoogle Scholar
- 37.Shin WS, Hong Y, Lee HW, Lee ST (2016) Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-kappaB in esophageal squamous cell carcinoma cells. Oncotarget 7(45):73242–73256. doi: 10.18632/oncotarget.12303 CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW (2011) Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Mol Cancer Res MCR 9(12):1767–1779. doi: 10.1158/1541-7786.MCR-10-0467 CrossRefPubMedGoogle Scholar
- 42.Chen YJ, Lee YC, Huang CH, Chang LS (2016) Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFkappaB/c-Jun activation in breast cancer MDA-MB-231 cells. Toxicol Appl Pharmacol 310:98–107. doi: 10.1016/j.taap.2016.09.007 CrossRefPubMedGoogle Scholar
- 43.Yeh CB, Hsieh MJ, Hsieh YH, Chien MH, Chiou HL, Yang SF (2012) Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity. PLoS One 7(2):e31055. doi: 10.1371/journal.pone.0031055 CrossRefPubMedPubMedCentralGoogle Scholar